GSK

GSK | NYSE

Price Alert Chart Builder DCF Calculator

$50.69

-$0.39 (-0.76%)

Sep 22, 2026, 1:34 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	33.25B	32.78B	32.67B	32.17B	31.63B	31.53B	31.38B	31.31B	31.45B	30.74B	30.33B	29.65B	29.33B	29.09B	29.32B	31.48B	30.27B	29.18B	29.41B	28.62B	30.64B	32.43B
Cost of Revenue	8.9B	8.96B	9.02B	8.92B	9.06B	9.02B	9.05B	8.91B	8.78B	8.59B	8.57B	8.39B	8.54B	8.78B	9.55B	11B	10.59B	10.12B	9.88B	9.38B	10.24B	10.99B
Gross Profit	24.35B	23.83B	23.65B	23.25B	22.57B	22.51B	22.33B	22.4B	22.66B	22.15B	21.76B	21.27B	20.8B	20.31B	19.77B	20.48B	19.68B	19.06B	19.53B	19.25B	20.4B	21.44B
Operating Income	8.8B	8.42B	8.34B	7.53B	5.12B	4.75B	4.02B	3.9B	5.66B	6.15B	6.75B	8.04B	7.28B	6.22B	6.43B	5.46B	5.65B	5.84B	5.24B	5.41B	5.89B	7.46B
Interest Income	106.3M	98M	130M	79M	85M	59M	37M	123.98M	115.98M	124.98M	121.98M	110.86M	108.86M	96.86M	74.86M	51M	33M	19M	22M	25.85M	21.85M	15.85M
Pretax Income	5.91B	7.44B	7.4B	7.01B	4.62B	4.23B	3.48B	3.29B	5.02B	5.51B	6.06B	7.31B	6.53B	5.44B	5.63B	4.71B	4.89B	5.06B	4.49B	4.6B	5.08B	6.65B
Net Income	4.82B	5.83B	5.72B	5.49B	3.42B	3.15B	2.58B	2.51B	4.03B	4.48B	4.93B	6.04B	15.4B	14.61B	14.92B	14.21B	4.76B	5.31B	4.59B	4.51B	4.39B	5.26B
Selling & General & Admin	9.2B	9.14B	9.09B	9.11B	10.67B	11B	11.02B	11.03B	9.53B	9.33B	9.39B	9.15B	8.91B	8.7B	8.37B	9.19B	8.82B	8.44B	9.06B	8.96B	9.95B	10.97B
Research & Development	7.46B	7.76B	7.53B	7.21B	6.98B	6.43B	6.4B	6.42B	6.53B	6.4B	6.22B	5.97B	5.74B	5.65B	5.49B	5.14B	5.21B	5.13B	5.15B	5.17B	4.9B	5.03B
Other Expenses	-1.12B	-1.48B	-1.3B	-599M	-200M	340M	891M	1.06B	947M	269M	-590M	-1.89B	-1.13B	-265M	-523M	686M	9M	-356M	79M	-290M	-332M	-2.02B
Operating Expenses	15.55B	15.41B	15.31B	15.72B	17.45B	17.77B	18.31B	18.51B	17.01B	16B	15.02B	13.23B	13.52B	14.08B	13.34B	15.02B	14.04B	13.22B	14.28B	13.84B	14.51B	13.98B
Interest Expense	690.95M	692M	687M	657M	646M	636M	640M	771.41M	797.41M	808.41M	845.41M	828.17M	846.17M	865.17M	867.17M	796.82M	791.82M	779.82M	775.82M	819.8M	822.8M	859.8M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	24.44B	24.37B	24.33B	24.64B	26.51B	26.78B	27.36B	27.41B	25.79B	24.59B	23.58B	21.61B	22.05B	22.86B	22.89B	26.02B	24.62B	23.34B	24.17B	23.21B	24.75B	24.97B
Income Tax Expense	639.97M	1.08B	1.11B	951M	638M	588M	526M	445M	703M	754M	756M	776M	752M	660M	707M	482M	495M	144M	79M	285M	280M	682M
Shares Outstanding (Basic)	2.01B	2.01B	1B	2.02B	2.03B	2.04B	2.04B	2.04B	2.04B	2.03B	2.03B	2.03B	2.03B	2.02B	2.02B	2.02B	2.01B	2.01B	2B	2B	2B	2B
Shares Outstanding (Diluted)	2.03B	2.04B	1.02B	2.05B	2.06B	2.07B	2.07B	2.04B	2.06B	2.06B	2.06B	2.06B	2.05B	2.04B	2.05B	2.04B	2.03B	2.03B	2.04B	2.03B	2.02B	2.01B
EPS (Basic)	2.92	3.42	3.36	2.72	1.70	1.56	1.28	1.24	2	2.22	2.44	3	7.66	7.28	7.44	7.08	2.28	2.56	2.20	2.16	2.20	2.64
EPS (Diluted)	2.88	3.36	3.28	2.66	1.66	1.52	1.24	1.20	1.96	2.20	2.42	2.98	7.56	7.18	7.34	6.96	2.24	2.52	2.18	2.16	2.20	2.62
EBITDA	10.68B	11.27B	11.59B	10.8B	8.61B	7.69B	6.67B	6.71B	8.09B	8.4B	9.08B	10.21B	9.83B	9.22B	9.19B	8.16B	8.29B	8.07B	7.44B	9.42B	9.63B	10.89B
EBIT	8.47B	8.13B	8.09B	7.67B	5.27B	4.87B	4.12B	3.94B	5.7B	6.2B	6.79B	8.1B	7.34B	6.27B	6.45B	5.5B	5.68B	5.84B	5.26B	5.39B	5.87B	7.48B
Depreciation & Amortization	2.21B	3.14B	3.5B	3.13B	3.35B	2.83B	2.55B	2.76B	2.39B	2.2B	2.29B	2.11B	2.49B	2.95B	2.73B	2.66B	2.61B	2.24B	2.18B	4.03B	3.76B	3.41B